Log in to save to my catalogue

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_1982096

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite the recent progress, multiple myeloma (MM) is still essentially incurable and there is a need for additional effective treatments with good tolerability. RO7297089 is a novel bispecific BCMA/CD16A-directed innate cell engager (ICE
®
) designed to induce BCMA+ MM cell lysis through high affinity binding of CD16A and retargeting of NK c...

Alternative Titles

Full title

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_osti_scitechconnect_1982096

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_1982096

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-021-01478-w

How to access this item